Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma.

Sun D, Yang Z, Fu Y, Chen Y, Wang S, Zhang Y, Ma Y, Zhang X.

Tumour Biol. 2014 Sep;35(9):8787-93. doi: 10.1007/s13277-014-2148-x. Epub 2014 May 31.

PMID:
24879626
2.

Diagnostic Value of Serum Epstein-Barr Virus Capsid Antigen-IgA for Nasopharyngeal Carcinoma: a Meta-Analysis Based on 21 Studies.

Chen Y, Xin X, Cui Z, Zheng Y, Guo J, Chen Y, Lin Y, Su G.

Clin Lab. 2016;62(6):1155-66. Review.

PMID:
27468579
3.

Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations.

Han BL, Xu XY, Zhang CZ, Wu JJ, Han CF, Wang H, Wang X, Wang GS, Yang SJ, Xie Y.

Asian Pac J Cancer Prev. 2012;13(6):2577-81. Review.

4.

Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.

Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB, Haryana SM, Middeldorp JM.

Int J Cancer. 2006 Aug 1;119(3):608-14.

5.

Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer.

Zhang X, Zhang Y, Nie Y, Wang S, Chen Y, Sun D.

Tumour Biol. 2014 Jul;35(7):6879-86. doi: 10.1007/s13277-014-1940-y. Epub 2014 Apr 16.

PMID:
24737587
6.

Detection of Epstein-Barr virus DNA in serum or plasma for nasopharyngeal cancer: a meta-analysis.

Liu Y, Fang Z, Liu L, Yang S, Zhang L.

Genet Test Mol Biomarkers. 2011 Jul-Aug;15(7-8):495-502. doi: 10.1089/gtmb.2011.0012. Epub 2011 Mar 16.

PMID:
21410354
7.
8.

Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.

Zheng XH, Lu LX, Li XZ, Jia WH.

Cancer Sci. 2015 Sep;106(9):1196-201. doi: 10.1111/cas.12718. Epub 2015 Jul 14.

9.

Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis.

Zhang J, Shu C, Song Y, Li Q, Huang J, Ma X.

Medicine (Baltimore). 2016 Oct;95(40):e5130. Review.

10.

EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.

Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH.

Int J Cancer. 2003 Jul 10;105(5):706-9.

11.

[Evaluation of detection of Epstein-Barr virus Rta/IgG in nasopharyngeal carcinoma].

Zheng YM, Cain YL, Cheng JR, Li J, Mo YK, Gao JQ, Dong ZR, Zhong QY.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Aug;23(4):285-7. Chinese.

PMID:
20108775
13.
14.

[Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].

Li XM, Yang CZ, Chen PJ, Su ZL, Song Y.

Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2000 Sep;14(9):400-1. Chinese.

PMID:
12563909
15.

Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment.

Adham M, Greijer AE, Verkuijlen SA, Juwana H, Fleig S, Rachmadi L, Malik O, Kurniawan AN, Roezin A, Gondhowiardjo S, Atmakusumah D, Stevens SJ, Hermani B, Tan IB, Middeldorp JM.

Clin Cancer Res. 2013 Apr 15;19(8):2175-86. doi: 10.1158/1078-0432.CCR-12-2897. Epub 2013 Mar 14.

16.

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.

Cancer. 2004 Mar 15;100(6):1162-70.

17.

Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.

Zheng XH, Lu LX, Cui C, Chen MY, Li XZ, Jia WH.

Oncotarget. 2016 Jan 26;7(4):4972-80. doi: 10.18632/oncotarget.6649.

18.

Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.

Chan KC, Hung EC, Woo JK, Chan PK, Leung SF, Lai FP, Cheng AS, Yeung SW, Chan YW, Tsui TK, Kwok JS, King AD, Chan AT, van Hasselt AC, Lo YM.

Cancer. 2013 May 15;119(10):1838-44. doi: 10.1002/cncr.28001. Epub 2013 Feb 21.

19.

Diagnostic value of Epstein-Barr virus capsid antigen-IgA in nasopharyngeal carcinoma: a meta-analysis.

Li S, Deng Y, Li X, Chen QP, Liao XC, Qin X.

Chin Med J (Engl). 2010 May 5;123(9):1201-5. Review.

PMID:
20529563
20.

An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma.

Le QT, Zhang Q, Cao H, Cheng AJ, Pinsky BA, Hong RL, Chang JT, Wang CW, Tsao KC, Lo YD, Lee N, Ang KK, Chan AT, Chan KC.

Clin Cancer Res. 2013 Apr 15;19(8):2208-15. doi: 10.1158/1078-0432.CCR-12-3702. Epub 2013 Mar 4.

Supplemental Content

Support Center